Poplar Point Capital Partners Lp - Jan 27, 2025 Form 4 Insider Report for NovaBay Pharmaceuticals, Inc. (NBY)

Role
10%+ Owner
Signature
/s/ Jad Fakhry, as authorized person for Joint Reporting Persons
Stock symbol
NBY
Transactions as of
Jan 27, 2025
Transactions value $
$67,700
Form type
4
Date filed
4/15/2025, 12:11 PM
Previous filing
Apr 7, 2025
Next filing
Apr 15, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NBY Common Stock, par value $0.01 per share Purchase $21.9K +31.7K +6.12% $0.69 550K Jan 27, 2025 Direct F1
transaction NBY Common Stock, par value $0.01 per share Purchase $45.8K +70.7K +12.85% $0.65 621K Jan 31, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being jointly filed by Poplar Point Capital Partners LP ("PPCP"), Poplar Point Capital Management LLC ("PPCM"), Poplar Point Capital GP LLC ("PPCGP"), and Mr. Jad Fakhry (collectively with PPCP, PPCM and PPCGP, the "Reporting Persons") with respect to shares of common stock of the above named issuer owned by PPCP. PPCM is the investment manager of PPCP. PPCGP is the general partner of PPCP. Mr. Fakhry is the manager of PPCM and PPCGP, and owns a controlling interest in, PPCM and PPCGP. The filing of this statement shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any securities covered by the statement other than the securities actually owned by such person (if any).